Monday, February 01, 2016
Drug maker Ipca Laboratories Ltd on Monday said that the US FDA issued it a warning letter for three of its factories located at Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa). “Ipca receives warning letter from US FDA for Ratlam (Madhva Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa) manufacturing units,” Ipca Laboratories Ltd said in a filing to the Bombay Stock Exchange on February 01, 2016. The US health regulator had issued the company a warning letter highlighting manufacturing quality lapses at its manufacturing units. These manufacturing factories have already been banned from supplying to the United States after the FDA inspected them in July 24, 2014, January 23, 2015 and March 25, 2015. The drug maker said it has since been trying to fix the problems and has been informing the FDA of its remedial measures. The company further said that it is fully committed to resolving these issues at the earliest. Meanwhile, shares of the company were trading at Rs 639.90 apiece, down 4.33 per cent, from previous close on BSE at 13:30 hours.